Potential Therapeutic Strategies to Combat HCC

Area of Science:

• Hepatocellular carcinoma (HCC) research
• Molecular oncology
• Cancer signaling pathways

Background:

• Hepatocellular carcinoma (HCC) is a prevalent and complex cancer characterized by genetic and phenotypic heterogeneity.
• HCC involves multiple signaling pathways including Vascular Endothelial Growth Factor, Epidermal Growth Factor Receptors (EGFR), and mammalian target of rapamycin (mTOR).

Purpose of the Study:

• To review current therapeutic mediators for Hepatocellular carcinoma (HCC).
• To discuss ongoing clinical trials and future prospects in HCC treatment.

Main Methods:

• Literature review of molecular mechanisms in HCC.
• Analysis of clinical data on multi-kinase cascade blockers.

Main Results:

• Multi-kinase inhibitors like sorafenib, selumetinib, and regorafenib have improved survival in progressive HCC.
• Molecular systemic therapy shows potential for HCC treatment.

Conclusions:

• Targeted molecular therapies represent a significant advancement in HCC treatment.
• Continued exploration of molecular mediators is crucial for improving cure rates in liver cancer.